Zobrazeno 1 - 10
of 68
pro vyhledávání: '"C. Bernard‐Marty"'
Publikováno v:
European Journal of Cancer. 138:S56
Autor:
C. Lagadic, C Bernard-Marty, E. Pons-Tostivint, Pascale Grosclaude, J. Goddard, Laetitia Daubisse-Marliac, Charlotte Vaysse, C Dunet, J L L Lacaze, C Morel, L Sibrac, E. Bauvin, Y Bergé, E Oum Sack
Publikováno v:
Breast, Vol 51, Iss, Pp 1-(2020)
The Breast : official journal of the European Society of Mastology
The Breast : official journal of the European Society of Mastology
Introduction We evaluate breast cancer (BC) pathway at a regional level including public, private and university institutions. We assessed the quality of multidisciplinary team meetings (MTM) and compliance with a panel of European high-quality indic
Autor:
Stéphanie Lozano, Stéphane Gérard, Marie-Eve Rouge-Bugat, C. Bernard-Marty, G. Abellan Van Kan, Loic Mourey, Thomas Filleron, Yves Rolland, A. Lefort, Matteo Cesari, Vincent Soler, Bruno Vellas, D. Brechemier, Laurent Balardy
Publikováno v:
The journal of nutrition, healthaging. 20(8)
The estimation of the risk of poor tolerance and overdose of antineoplastic agents protocols represents a major challenge in oncology, particularly in older patients. We hypothesize that age-related modifications of body composition (i.e. increased f
Autor:
N. Bahmad, J.F. Tournamille, V. Priou, G. Lebozec, N. Perez-staub, C. bernard Marty, R. Alfonsi, M.A. Mouret-reynier, C. Blein, M.C. Borg, H. Attar-rabia, C. Pers-regouby, A. Jaffre, J. Forget, Z. El Islami
Publikováno v:
European Journal of Cancer. 92:S106-S107
Autor:
V. Priou, R. Alfonsi, G. Lebozec, C. bernard Marty, C. Blein, H. Attar Rabia, J.F. Tournamille, M.A. Mouret-reynier, M.C. Borg, A. Jaffre, N. Bahmad, N. Perez staub
Publikováno v:
Value in Health. 21:S30
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Denis Larsimont, Marianne Paesmans, Isabelle Veys, Virginie Durbecq, Martine Piccart, Christine Desmedt, Nicolas Sirtaine, C. Bernard-Marty, J.M. Nogaret, Christos Sotiriou, Lieveke Ameye
Publikováno v:
Critical Reviews in Oncology/Hematology. 67:80-92
Introduction To investigate the influence of ageing on the incidence of breast cancer (BC) molecular subtypes, patient age at diagnosis was correlated with bio-pathological data collected retrospectively from 2723 consecutive patients diagnosed/treat
Autor:
S. Taillibert, Jacques Bonneterre, R. Conforti, Thomas Bachelot, E. Le Rhun, C. Bernard-Marty
Publikováno v:
Cancer/Radiothérapie
Cancer/Radiothérapie, 2015, 19 (1), pp.36-42. ⟨10.1016/j.canrad.2014.12.003⟩
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2015, 19 (1), pp.36-42. ⟨10.1016/j.canrad.2014.12.003⟩
Cancer/Radiothérapie, 2015, 19 (1), pp.36-42. ⟨10.1016/j.canrad.2014.12.003⟩
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2015, 19 (1), pp.36-42. ⟨10.1016/j.canrad.2014.12.003⟩
Resume En raison d’un accroissement constant de l’arsenal therapeutique disponible dans le cancer du sein, et du developpement de therapies ciblees, en particulier ciblant HER2 (human epidermal growth factor receptor 2), la survie des patientes s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dbb6f214966075315ab3a8c6170ade6
https://hal.science/hal-02939549
https://hal.science/hal-02939549
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 19(1)
An increase in the incidence of breast cancer patients with brain metastases has been observed over the last years, mainly because the recent development of new drugs including therapies targeting HER2 (human epidermal growth factor receptor 2) resul
Autor:
A.‐L. Ranc Royo, B. De Lafontan, D. Guerrero, P. Dulguerova, V. Sibaud, N. Levasseur, C. Bernard‐Marty, J.‐M. Levecq, C. Massabeau, J. Guyonnaud, S. Salas, Virginie Ribet, C. Sarda, A.B. Rossi, F. Dalenc
Publikováno v:
European Journal of Cancer Care. 27:e12735
This study investigated the efficacy of post-treatment hydrotherapy as supportive care for management of persistent/long-lasting dermatologic adverse events (dAEs) induced in breast cancer survivors by adjuvant therapy, and its impact on quality of l